HANGZHOU, China, Feb. 24, 2025 /PRNewswire-PRWeb/ — Hangzhou Viablife Biotech Co., Ltd., a leading innovator in biosynthesis and biofermentation technologies for food and dietary supplement ingredients, proudly announces that its highly-scalable biosynthesized Hydroxytyrosol has received…
Viablife Achieves U.S. FDA No Objection for Highly-Scalable Biosynthesized Hydroxytyrosol in Collaboration with REJIMUS, INC.
This post was originally published on this site